In the news | 13th April 2016
Pharma organizations are up against a drive to innovate more than ever before. Scott Weiss, Senior Director of Product Management, explains how they are responding.
New process definition capabilities in PIMS 5.1, further enhance quality assurance and “right-first-time” initiatives for pharma manufacturers.
Requirements to maintain a GxP environment means researchers must conduct software validation on any updated software so it continues to meet users’ needs.